GLENMEDE TRUST CO NA - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$297,015
-31.1%
10,082
-17.7%
0.00%0.0%
Q2 2023$430,8310.0%12,2430.0%0.00%0.0%
Q1 2023$430,831
-28.0%
12,243
-6.3%
0.00%
-50.0%
Q4 2022$598,684
-7.2%
13,066
-1.9%
0.00%0.0%
Q3 2022$645,000
-13.2%
13,313
-29.7%
0.00%0.0%
Q2 2022$743,000
+64.7%
18,924
+54.2%
0.00%
+100.0%
Q1 2022$451,000
-18.1%
12,270
+1.4%
0.00%
-33.3%
Q4 2021$551,000
+32.5%
12,106
+3.9%
0.00%
+50.0%
Q3 2021$416,000
+1881.0%
11,647
+1086.0%
0.00%
Q3 2020$21,0000.0%982
+8.0%
0.00%
Q2 2020$21,000
+425.0%
909
+109.0%
0.00%
Q1 2020$4,0000.0%4350.0%0.00%
Q4 2019$4,000
-33.3%
435
-28.5%
0.00%
Q3 2019$6,000
+20.0%
608
+21.4%
0.00%
Q2 2019$5,000
+150.0%
501
+75.2%
0.00%
Q1 2019$2,000
+100.0%
286
+27.7%
0.00%
Q4 2018$1,000224
+154.5%
0.00%
Q3 2016$0880.00%
Other shareholders
CYTOKINETICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$7,286,7218.83%
Saturn V Capital Management LP 406,225$13,251,0607.35%
Logos Global Management LP 1,650,000$53,823,0007.32%
Finepoint Capital LP 369,093$12,039,8144.16%
GREAT POINT PARTNERS LLC 600,000$19,572,0003.83%
Boxer Capital, LLC 2,100,000$68,5023.18%
PFM Health Sciences, LP 2,399,545$78,273,1583.04%
DAFNA Capital Management LLC 332,734$10,853,7832.97%
Integral Health Asset Management, LLC 650,000$21,203,0002.62%
Sofinnova Investments, Inc. 843,228$27,506,0971.80%
View complete list of CYTOKINETICS INC shareholders